OncoSec Medical Inc (ONCSQ)

[guti]

Nothing and something. A person needs to be informed as much as possible of anything that can affect their study and future. We can not predict what will happen, which is why the IF, but being well informed can guide them towards the correct path. And when encountered with a decision to be made, they have a greater chance of making the correct choice.

That's exactly what Oncosec did when they listened to Dr. Pierce and made the choice to focus only on ImmunoPulse IL-12 to help nonresponders by using anti PD-1. Keep in mind, after 2014 there was another choice other than Keytruda, since three months later of that same year Opdivo was also approved.

When you are planning to put money on a bio company, which you are probably planning to do with Oncosec else you would not follow it this long, there is nothing to base the speculation. Therefore, it is best to understand what the industry is doing in reference to the company. Immunotherapy is new, and Dr. Pierce spoke about it years before it began. But he never mentioned electroporation IL-12 until now.